A New Understanding

Posted by Allimax on 8/10/2016 to

SIBO (Small Intestinal Bacterial Overgrowth)

Irritable bowel syndrome (IBS) is the most common chronic medical condition and is characterized by abdominal pain, bloating, and altered bowel habits. Although there is some variation from study to study and country to country, up to 20% of a given population appears to be affected by this condition. In addition, unlike other chronic conditions such as heart disease, IBS commonly affects all ages. In fact, studies have shown that patients with IBS have a lower quality of life than those with heart disease or other chronic medical conditions. Despite these facts, developments that may identify causes for IBS have happened only recently. IBS remains a stigmatized condition by the nature of having gas, bloating, and bowel dysfunction: symptoms that fall prey to ridicule, but IBS is now recognized as a legitimate condition that can benefit from new theories and treatment strategies.

Scientists from around the world have shown the benefits of allicin (not garlic) in balancing the microbial terrain. Our patented process provides a guaranteed stable allicin that is bioactively potent with published research showing a broad spectrum effect against bacteria, fungus, parasites, and viruses. Clinicians have reported superior responses where pharmaceuticals are not preferred. AlliUltra and Allimed are the only products with bioactively stabilized allicin. AlliUltra® 's sophisticated refinement allows us to capture garlic's active component (Allicin) and deliver it directly to where your body needs it.